Automated description from the Alliance of Genome Resources (Release 9.0.0)
Enables G protein-coupled receptor activity; dopamine binding activity; and dopamine neurotransmitter receptor activity, coupled via Gi/Go. Involved in several processes, including hyaloid vascular plexus regression; negative regulation of innate immune response; and presynaptic modulation of chemical synaptic transmission. Acts upstream of or within several processes, including modulation of chemical synaptic transmission; nervous system development; and regulation of secretion. Located in several cellular components, including Golgi apparatus; axon; and dendrite. Is active in several cellular components, including GABA-ergic synapse; dopaminergic synapse; and synaptic membrane. Is expressed in several structures, including alimentary system; genitourinary system; nervous system; respiratory system; and sensory organ. Used to study Parkinson's disease and primary hyperaldosteronism. Human ortholog(s) of this gene implicated in several diseases, including alcohol dependence; drug dependence (multiple); end stage renal disease; nicotine dependence; and type 2 diabetes mellitus. Orthologous to human DRD2 (dopamine receptor D2).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.